Healthcare costs in Louisiana are skyrocketing, and patients and their families are feeling the pressure. Nearly 80% of Louisianans worry about affording care, and 60% have delayed or skipped treatment because of cost. This isn’t sustainable; it’s time for change.
At the heart of the problem? Pharmacy Benefit Managers (PBMs). These middlemen control 94% of prescription drug claims nationwide, and in Louisiana, Express Scripts alone holds 71% of the market. PBMs design formularies that favor expensive drugs, restrict patient choice, and drive up costs—all while pocketing profits.
Congress has the power to fix this. H.R. 4317, the PBM Reform Act of 2025, offers real solutions:
- Ban spread pricing in Medicaid
- Increase transparency
- Break the link between PBM revenue and drug prices
- Ensure rebates go directly to patients at the point of sale
This is a bipartisan issue with broad support. Passing PBM reform before year-end would be one of the most impactful steps Congress can take to make prescriptions affordable for American families.
